Pfizer: COVID-19 Vaccine May be Ready by September

on

April 29, 2020. By Taiwo Adebulu

Pfizer, an American biopharmaceutical company, says its COVID-19 vaccine could be ready for emergency use by September.

The pharmaceutical giant, on Tuesday, said it will begin testing of the experimental vaccine in the US next week.

This is coming a week after Germany approved human trial of a possible COVID-19 vaccine. The vaccine, named BNT162, was developed by Biontech, a Mainz-based company.

Ginna Crochets IMG-20200428-WA0009

The company had said the vaccine would be tested in the US after the human trials in Germany.

The United Kingdom had also announced that there would be clinical trials of a potential COVID-19 vaccine.

The World Health Organisation (WHO) said there are about 20 different potential COVID-19 vaccines currently in development.

Some of the companies working on a vaccine said they are accelerating the timeline for testing as experts predict that the COVID-19 pandemic may last till 2021.

Book Store

According to Worldometer, confirmed cases of COVID-19 globally have risen to 3,150,478, with 218,466 deaths. But 964,161 persons have recovered.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s